We’re thrilled to see Lotus Health score their first $35M Series A funding round. Venture capital firms CRV and Kleiner Perkins co-led this impressive investment. The company’s goal is to disrupt the typical primary care model with a tech-forward approach—including artificial intelligence and telemedicine to serve patients. Lotus Health recently raised $41 million in Series A funding to introduce Lotus Health AI. This no-cost primary care service, available 24/7 in over 50 languages, launched in May of 2024.
KJ Dhaliwal quickly noticed some major inefficiencies in the U.S. healthcare industry. In reaction, he started the company to solve these problems. His own experiences acting as a medical translator for his immigrant parents inspired his desire to improve healthcare accessibility. Dhaliwal’s vision is to develop an AI model that synthesizes the latest evidence-based research with a patient’s history and clinical answers to generate personalized treatment plans.
Lotus Health AI functions along telemedicine models that exploded in popularity during the COVID-19 pandemic. This new, flexible, and innovative approach provides patients with the high-quality primary care services they need and deserve without the common barriers seen in traditional healthcare environments. Lotus’s implementation of a model like OpenEvidence. This new model produces accurate, personalized medical information that is reviewed, edited, and approved by board-certified physicians in real-time.
“The AI is giving the advice, but the real doctors are actually signing off on it,” said KJ Dhaliwal, emphasizing the importance of human oversight in the decision-making process.
Saar Gur, a general partner at CRV, assuredly took the lead on the funding deal for Lotus Health. He thinks the company will be able to overcome the existing regulatory and engineering challenges. “There are many challenges, but it’s not SpaceX sending astronauts to the moon,” Gur noted, highlighting the realistic yet ambitious goals of the company.
Lotus Health’s innovative approach does not only aim to make healthcare more accessible. It also strives to create a more efficient system that prioritizes patient needs. Lotus Health merges cutting edge AI technology with a rich knowledge of patient history. This powerful combination has the potential to create a far more admirable, personalized, and convenient healthcare experience.
The company’s service model helps them serve a multicultural population as they support customers in over 50 languages. This innovative approach removes the linguistic barriers that deny millions of patients access to timely medical care. As an entrepreneur, Dhaliwal is deeply invested in inclusivity. He believes that everyone has a right to quality healthcare, regardless of who they are or where they come from.
The recent funding round is expected to take Lotus Health over the next major milestone. This investment will allow them to improve and expand their platform and deepen their penetration. The company plans to spend the new capital developing that technology. It’s looking to add to its growing cadre of healthcare professionals to help it reach those ambitious aims.
KJ Dhaliwal made his first exit selling the South Asian dating app Dil Mil for $50 million in 2019. This support has allowed him to chase his dream with passion and commitment, not only for Lotus Health but in building a sustainable movement to advance Lotus. The combination of his entrepreneurial spirit and personal experiences uniquely positions Dhaliwal to tackle some of the most pressing issues within the healthcare system.
Lotus Health is growing its product and continuing to develop its proprietary AI. It calls upon patients and health care providers alike to participate in this transformative endeavor. The company’s mission is clear: to fundamentally reimagine how primary care is delivered in an increasingly digital world.